[The syndrome of ovarian hyperstimulation].
The ovarian hyperstimulation syndrome (SHO) can be defined as an iatrogenic pathology induced by active substances administered for controlling follicular maturation and ovulation. The etiology, the physiopathology, the diagnostic and therapeutic methods available are discussed. A theoretical model, based on clinical data, allows identification of a set of criteria which should help determining prospectively the chances of development of such a pathology.
Germond
M
M
Départment de Gynécologie et d'Obstétrique, CHUV, Lausanne, Switzerland.
Gaillard
M C
MC
Senn
A
A
D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D008596:Menotropins / Q000008:administration & dosage*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors
D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins
Syndrome d'hyperstimulation ovarienne.